Rapid Determination of Blood Coagulation Factor XIII Activity Using Protein Arrays for Serodiagnosis of Human Plasma
- 16 February 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 83 (6) , 2317-2323
Abstract
We developed a novel on-chip assay using protein arrays for quantitative and rapid analysis of blood coagulation factor XIII (FXIII) activity in human plasma. FXIII is activated by concerted action of thrombin and Ca2+ and plays essential roles in hemostasis, angiogenesis, and wound healing. We fabricated protein arrays by immobilizing fibrinogen onto the 3-aminopropyltrimethoxysilane layer of well-type arrays and determined FM activity by analyzing biotinylated fibrinogen with Cy3-conjugated streptavidin. We determined optimal concentrations of Ca2+, thrombin, and S-(biotinamido)pentylamine (BAPA) for the on-chip activity assay, and the detection limit was 0.01 Lowey U/mL (9.9 pM). Using the on-chip activity assay, hepatocellular carcinoma patients (n = 24), but not hepatitis (n = 24) or liver cirrhosis patients (n = 41), had significantly lower FXIII activities (p < 0.001) than normal individuals (n = 41), indicating that FXIII activity is a possible diagnostic marker for hepatocellular carcinoma. In addition, we have successfully used this activity assay to reveal individual variations (37-57%, n = 65) in the inhibition rate of FXIII activity by isoniazid, the first-line antituberculosis agent. Thus, our optimized on-chip FXIII activity assay provides a quantitative and high-throughput approach to investigating the role(s) of FXIII in human diseases. Moreover, it has a strong potential to be applied toward FXIII-related personalized medicines.Keywords
This publication has 27 references indexed in Scilit:
- Transglutaminase 2: a multi-functional protein in multiple subcellular compartmentsAmino Acids, 2010
- Label-free and quantitative analysis of C-reactive protein in human sera by tagged-internal standard assay on antibody arraysBiosensors and Bioelectronics, 2009
- Measurement of Hemostatic Factors in EDTA PlasmaAmerican Journal of Clinical Pathology, 2008
- Factor XIII deficiencyHaemophilia, 2008
- Evaluation of EDTA hematology tubes for collection of blood samples for tests of secondary hemostasis in dogsAmerican Journal of Veterinary Research, 2008
- Hemostatic Alterations in Liver Disease: A Review on Pathophysiology, Clinical Consequences, and TreatmentDigestive Surgery, 2007
- Development and evaluation of a modified colorimetric solid‐phase microassay for measuring the activity of cellular and plasma (Factor XIII) transglutaminasesBiotechnology and Applied Biochemistry, 2006
- Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6‐year survival in patients with chronic liver diseaseLiver International, 2006
- Factor XIII (FXIII) and angiogenesisJournal of Thrombosis and Haemostasis, 2006
- A Contribution to the Pathology of Acquired Plasma Factor XIII DeficiencySeminars in Thrombosis and Hemostasis, 1985